3-O-TRIETHYLSILYL-4,6-O-DI-(TERT.-BUTYL)-SILANE-DIYL-D-GLUCAL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | DCCROFev4dM |
|---|---|
| InChI | InChI=1S/C20H40O4Si2/c1-10-25(11-2,12-3)23-16-13-14-21-17-15-22-26(19(4,5)6,20(7,8)9)24-18(16)17/h13-14,16-18H,10-12,15H2,1-9H3/t16-,17-,18+/m1/s1 |
| InChIKey | UYYQOFFIFBKTAO-KURKYZTESA-N |
| Mol Weight | 400.7 g/mol |
| Molecular Formula | C20H40O4Si2 |
| Exact Mass | 400.246513 g/mol |
| Enantiomer InChIKey | UYYQOFFIFBKTAO-OKZBNKHCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
D-ribo-Hex-1-enitol, 1,5-anhydro-2-deoxy-4,6-O-(phenylmethylene)-3-O-[tris(1-methylethyl)silyl]-
2,6-ANHYDRO-1-PHENYL-1-KETO-3,7-DIDEOXY-4-O-METHYL-5-O-TRT.-BUTYLDIMETHYLSILYL-D-ALTRO-HEPT-2-ENITOL
.beta.-D-Allopyranoside, tetradecyl 6-deoxy-4-O-[(1,1-dimethylethyl)dimethylsilyl]-2,3-di-O-methyl-
Glucopyranoside, methyl 4-O-methyl-2,3,6-tris-O-(trimethylsilyl)-, .beta.-d-
(1R,2R,4S,5S)-2-(tert-Butyldimethylsilyloxy)-4-triethylsilyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one
Methyl 2-O-methyl-pertrimethylsilyl-.alpha.-D-glucopyranoside
Methyl (3S,4R,5R,6S)- 5-[1'-(t-butyl)-1',1'-dimethylsilyloxy]-3,4,6-trihydroxy-1-cyclohexene-1-carboxylate
2-Deoxy-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-dioxanediyl]-D-erythro-pentanoic acid .gamma.-lactone
(R)-2-(tert-Butyl-diphenyl-silanyloxy)-1-[(2S,5R)-5-((R)-1-hydroxy-propyl)-tetrahydro-furan-2-yl]-pent-4-en-1-ol
(2R,3R,4R,5S,6S)-6-tert-Butyldiphenylsilyloxymethyl-3,4-epoxy-3,4,5,6-tetrahydro-5-hydroxy-2-methoxy-2H-pyran
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and antifungal properties of papulacandin derivatives | Beilstein Journal of Organic Chemistry | 2012 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.